Gi-Young Sohn
Amministratore Delegato presso ENZYCHEM LIFESCIENCES CORPORATION
Patrimonio netto: 6 M $ in data 30/04/2024
Posizioni attive di Gi-Young Sohn
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| ENZYCHEM LIFESCIENCES CORPORATION | Direttore/Membro del Consiglio | - | - |
| Amministratore Delegato | 01/06/2012 | - | |
| Presidente | 01/06/2012 | - | |
Bridget Lifesciences Corp.
 Bridget Lifesciences Corp. Financial ConglomeratesFinance Bridget Lifesciences Corp. functions as an investment holding South Korean company. Hye-Kyung Kim has been the CEO of the private company since 2003. | Presidente | 01/01/2003 | - |
Storia della carriera di Gi-Young Sohn
Formazione di Gi-Young Sohn
| Korea University | Graduate Degree |
Statistiche
Distribuzione geografica
| Corea del Sud | 4 |
Posizioni
| Chairman | 2 |
| Director/Board Member | 1 |
| Chief Executive Officer | 1 |
Settori
| Health Technology | 2 |
| Consumer Services | 2 |
| Finance | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| ENZYCHEM LIFESCIENCES CORPORATION | Health Technology |
| Aziende private | 1 |
|---|---|
Bridget Lifesciences Corp.
Bridget Lifesciences Corp. Financial ConglomeratesFinance Bridget Lifesciences Corp. functions as an investment holding South Korean company. Hye-Kyung Kim has been the CEO of the private company since 2003. | Finance |
- Borsa valori
- Insiders
- Gi-Young Sohn
- Esperienza
